Technical Analysis for LABS - Medipharm Labs Corp.

Grade Last Price % Change Price Change
grade D 4.27 0.00% 0.000
LABS closed unchanged on Tuesday, October 22, 2019, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Nov 13

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical LABS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
200 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 200 DMA Bearish -0.70%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.70%
20 DMA Support Bullish -0.70%
NR7 Range Contraction -0.70%

Older signals for LABS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MediPharm Labs, through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
Medicine Cannabis Entheogens Euphoriants Medicinal Plants Herbalism Medical Cannabis Cannabis In Canada Health Sciences Pharmaceuticals Policy Legality Of Cannabis Access To Cannabis For Medical Purposes Regulations Business To Business Licensed Producer Licensed Producers Medical Cannabis Products
Is LABS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.39
52 Week Low 0.91
Average Volume 942,225
200-Day Moving Average 4.3315
50-Day Moving Average 4.75
20-Day Moving Average 4.1145
10-Day Moving Average 4.114
Average True Range 0.3501
ADX 14.08
+DI 24.1957
-DI 21.262
Chandelier Exit (Long, 3 ATRs ) 3.9297
Chandelier Exit (Short, 3 ATRs ) 4.1503
Upper Bollinger Band 4.8183
Lower Bollinger Band 3.4107
Percent B (%b) 0.61
BandWidth 34.210718
MACD Line -0.1303
MACD Signal Line -0.2113
MACD Histogram 0.0809
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.525
Resistance 3 (R3) 4.507 4.403 4.483
Resistance 2 (R2) 4.403 4.338 4.413 4.468
Resistance 1 (R1) 4.337 4.298 4.370 4.355 4.454
Pivot Point 4.233 4.233 4.250 4.243 4.233
Support 1 (S1) 4.167 4.168 4.200 4.185 4.086
Support 2 (S2) 4.063 4.128 4.073 4.072
Support 3 (S3) 3.997 4.063 4.058
Support 4 (S4) 4.015